Ignite Creation Date:
2025-12-24 @ 1:01 PM
Ignite Modification Date:
2025-12-27 @ 9:56 PM
Study NCT ID:
NCT01934361
Status:
COMPLETED
Last Update Posted:
2020-12-09
First Post:
2013-08-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase Ib/II Study of Buparlisib Plus Carboplatin or Lomustine in Patients With Recurrent Glioblastoma Multiforme
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-02-28
Start Date Type:
ACTUAL
Primary Completion Date:
2016-07-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-07-07
Completion Date Type:
ACTUAL
First Submit Date:
2013-08-20
First Submit QC Date:
None
Study First Post Date:
2013-09-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-06
Last Update Post Date:
2020-12-09
Last Update Post Date Type:
ACTUAL